Morgan Stanley’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Buy |
|
|||||
|
2025
Q1 | $19M | Buy |
|
|||||
|
2024
Q4 | $14.8M | Buy |
|
|||||
|
2024
Q3 | $10.8M | Buy |
|
|||||
|
2024
Q2 | $5.64M | Sell |
|
|||||
|
2024
Q1 | $6.53M | Sell |
|
|||||
|
2023
Q4 | $26.2M | Buy |
|
|||||
|
2023
Q3 | $11.1M | Sell |
|
|||||
|
2023
Q2 | $16.3M | Sell |
|
|||||
|
2023
Q1 | $20.5M | Buy |
|
|||||
|
2022
Q4 | $6.43M | Buy |
|
|||||
|
2022
Q3 | $11M | Sell |
|
|||||
|
2022
Q2 | $29.1M | Sell |
|
|||||
|
2022
Q1 | $37.7M | Sell |
|
|||||
|
2021
Q4 | $109M | Sell |
|
|||||
|
2021
Q3 | $148M | Buy |
|
|||||
|
2021
Q2 | $46.9M | Buy |
|
|||||
|
2021
Q1 | $3.98M | Sell |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|
|||||
|
2020
Q3 | $1.84M | Buy |
|
|||||
|
2020
Q2 | $1.54M | Buy |
|
|||||
|
2020
Q1 | $809K | Sell |
|
|||||
|
2019
Q4 | $4.97M | Buy |
|
|||||
|
2019
Q3 | $131K | Buy |
|
|||||
|
2019
Q2 | $149K | Sell |
|
|||||
|
2019
Q1 | $214K | Sell |
|
|||||
|
2018
Q4 | $595K | Buy |
|
|||||
|
2018
Q3 | $334K | Sell |
|
|||||
|
2018
Q2 | $429K | Sell |
|
|||||
|
2018
Q1 | $3.15M | Buy |
|
|||||
|
2017
Q4 | $1.67M | Sell |
|
|||||
|
2017
Q3 | $3.58M | Buy |
|
|||||
|
2017
Q2 | $3.45M | Buy |
|
|||||
|
2017
Q1 | $3.27M | Buy |
|
|||||
|
2016
Q4 | $8K | Buy |
|
|||||
|
2016
Q3 | $6K | Hold |
|
|||||
|
2016
Q2 | $6K | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|
|||||
|
2015
Q4 | $2K | Buy |
|
|||||
|
2015
Q3 | $3K | Sell |
|
|||||
|
2015
Q2 | $3K | Buy |
|
|||||
|
2015
Q1 | $0 | Hold |
|
|||||
|
2014
Q4 | $0 | Hold |
|
|||||
|
2014
Q3 | $0 | Buy |
|